Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Private Wealth Partners LLC lessened its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 425,358 shares of the biopharmaceutical company’s stock after selling 43,646 shares during the quarter. Pfizer comprises 1.0% of Private Wealth […]
Golden State Equity Partners grew its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 134.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,493 shares of the biopharmaceutical company’s stock after purchasing an additional 14,607 shares during the quarter. Golden […]
Syon Capital LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 111.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,444 shares of the biopharmaceutical company’s stock after purchasing an additional 33,961 shares during […]
Birchcreek Wealth Management LLC lessened its position in The Home Depot, Inc. (NYSE:HD – Free Report) by 8.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,851 shares of the home improvement retailer’s stock after selling 179 shares during the quarter. Birchcreek Wealth Management LLC’s holdings in Home Depot were worth $641,000 […]
Anchor Capital Advisors LLC lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,167 shares of the medical research company’s stock after selling 1,762 shares during the quarter. […]
Resonant Capital Advisors LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 97,898 shares of the biopharmaceutical company’s stock after purchasing an additional 9,762 shares during the quarter. Resonant Capital […]
Financial Perspectives Inc trimmed its position in shares of Shopify Inc. (NYSE:SHOP – Free Report) (TSE:SHOP) by 15.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,051 shares of the software maker’s stock after selling 2,720 shares during the quarter. Financial Perspectives Inc’s […]
John G Ullman & Associates Inc. trimmed its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 29.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 407,708 shares of the biopharmaceutical company’s stock after selling 169,128 shares during the quarter. Pfizer […]
Bahl & Gaynor Inc. lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,291 shares of the medical research company’s stock after selling 75 shares during the quarter. Bahl & […]
Naviter Wealth LLC raised its position in shares of Visa Inc. (NYSE:V – Free Report) by 21.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,435 shares of the credit-card processor’s stock after purchasing an additional 1,647 shares during the period. Naviter Wealth […]
Consolidated Planning Corp lessened its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 36.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 9,782 shares of the biopharmaceutical company’s stock after selling 5,645 shares during the period. Consolidated Planning Corp’s holdings in Pfizer were worth $282,000 as of its most recent filing with the […]